| Authors: |
Daoud T; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 1422, 1515 Holcombe Blvd, Houston, Houston, TX, 77030, USA., Chen J; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wei P; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Wong F; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Yap TA; Department of Investigational Cancer Therapeutics (Phase I Program, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.; Therapeutics Discovery Division, The University of Texas MD Anderson Cancer Center, Houston, TX, USA., Lin LL; Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Unit 1422, 1515 Holcombe Blvd, Houston, Houston, TX, 77030, USA. LLLin@mdanderson.org. |
